HBV Use of cetylpyridinium chloride for anti-Hepatitis B virus

摘要

According to the present invention, disclosed is a pharmaceutical composition capable of preventing production of hepatitis B virus (HBV), containing cetylpyridinium chloride (CPC). The pharmaceutical composition, according to the present invention, is capable of inhibiting capsid assembly essential for HBV production particularly through interactions with capsid dimers, and exhibits synergistic effects when used in combination with conventional HBV polymerase inhibitors. Therefore, the pharmaceutical composition can be effectively used for the treatment and prevention of various diseases requiring inhibition of HBV production.